Riluzole (Brain Trust Bio)

利鲁唑 (Brain Trust Bio)

Report date: 2024/04/22 17:52:50

Base Information

Drug NameRiluzole (Brain Trust Bio)
Drug Alias NameRiluzole Intrathecal Drug Delivery Method (Brain Trust Bio)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit modulators
TargetsSodium channel alpha subunit
Therapy Area/IndicationsAmyotrophic Lateral SclerosisCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBrain Trust Bio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBrain Trust Bio Co Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A